Antisense Oligonucleotides for the Inhibition of Integrin av-Subunit Expression
Details for Australian Patent Application No. 2003271376 (hide)
International Classifications
Event Publications
22 January 2004 Complete Application Filed
29 January 2004 Application Open to Public Inspection
Published as AU-B-2003271376
22 December 2005 Assignment before Grant
Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH
5 April 2007 Application Accepted
Published as AU-B-2003271376
26 April 2007 Corrigenda
Applications Accepted - Name Index Under the name Sanofi-Aventis Deutschland GmbH, Application No. 2003271376, under INID (54) correct the title to read Antisense Oligonucleotides for the Inhibition of Integrin alpha-Subunit Expression
2 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser